scholarly journals Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity

Cell Reports ◽  
2019 ◽  
Vol 27 (12) ◽  
pp. 3422-3432.e4 ◽  
Author(s):  
Lynnette Marcar ◽  
Kankana Bardhan ◽  
Liliana Gheorghiu ◽  
Patrick Dinkelborg ◽  
Heike Pfäffle ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Parp Inhibitor ◽  
Acquired Resistance ◽  
Egfr Mutated ◽  
Inhibitor Treatment

scholarly journals Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer

Lung Cancer ◽  
2014 ◽  
Vol 83 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Norihiro Yamaguchi ◽  
Antonio R. Lucena-Araujo ◽  
Sohei Nakayama ◽  
Lorena L. de Figueiredo-Pontes ◽  
David A. Gonzalez ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Acquired Resistance ◽  
Egfr Inhibition
Sign in / Sign up

Export Citation Format

Share Document